Boston, MA -- (ReleaseWire) -- 06/05/2014 -- January 2013 saw the Irish launch of Nicorette QuickMist. The launch of this product was timed to maximise the elevated potential demand at this time of year as giving up smoking is a popular New Year's Resolution among many Irish smokers. Irish consumers have been aware of the existence of this product for some time, mainly through advertising on non-terrestrial television, with McNeil Healthcare (Ireland) Ltd benefiting from the worldwide advertising of the product by parent company Johnson & Johnson Inc. The product benefited from continuous advertising throughout 2013, which represents something of a departure from the more specific advertising period of Christmas and New Year which is usually applied to NRT smoking cessation aids.
McNeil Healthcare (Ireland) Ltd remained the leading company in NRT smoking cessation aids in 2013 with a 70% value share. The company's Nicorette brand remains extremely popular among Irish consumers and this is mainly thanks to highly successful advertising campaigns. The extent of Nicorette's popularity and its ubiquity have led to Nicorette becoming synonymous with NRT smoking cessation aids in general among a substantial proportion of the Irish population. The company continues to innovate in the category, expanding its product range in January 2013 with the launch of Nicorette QuickMist, which follows other ground-breaking products launched b y McNeil in the category, including NRT inhalators.
View Full Report Details and Table of Contents
NRT smoking cessation aids is expected to increase in value at a CAGR of 4% in constant 2013 terms over the forecast period. The number of Irish people choosing to quit smoking is expected to continue increasing as health concerns about the dangers of smoking and nicotine addiction gain ground. Equally, there is no evidence to suggest that the IMB will relax restrictions on the sale of NRT smoking cessation aids, ensuring consistently high unit prices and ensuring a positive value performance in the category for the foreseeable future.
Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in Ireland with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the NRT Smoking Cessation Aids industry in Ireland, our research will save you time and money while empowering you to make informed, profitable decisions.
The NRT Smoking Cessation Aids in Ireland market research report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Healthcare research reports at Fast Market Research
You may also be interested in these related reports:
- NRT Smoking Cessation Aids in Latvia
- NRT Smoking Cessation Aids in Canada
- NRT Smoking Cessation Aids in the United Kingdom
- NRT Smoking Cessation Aids in Spain
- NRT Smoking Cessation Aids in Brazil
- NRT Smoking Cessation Aids in South Korea
- NRT Smoking Cessation Aids in Slovenia
- NRT Smoking Cessation Aids in Bulgaria
- NRT Smoking Cessation Aids in Singapore
- NRT Smoking Cessation Aids in Mexico